Literature DB >> 24339742

Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Despoina Sakellariou1, Maria Chiourea, Christina Raftopoulou, Sarantis Gagos.   

Abstract

Human tumors using the alternative lengthening of telomeres (ALT) exert high rates of telomere dysfunction. Numerical chromosomal aberrations are very frequent, and structural rearrangements are widely scattered among the genome. This challenging context allows the study of telomere dysfunction-driven chromosomal instability in neoplasia (CIN) in a massive scale. We used molecular cytogenetics to achieve detailed karyotyping in 10 human ALT neoplastic cell lines. We identified 518 clonal recombinant chromosomes affected by 649 structural rearrangements. While all human chromosomes were involved in random or clonal, terminal, or pericentromeric rearrangements and were capable to undergo telomere healing at broken ends, a differential recombinatorial propensity of specific genomic regions was noted. We show that ALT cells undergo epigenetic modifications rendering polycentric chromosomes functionally monocentric, and because of increased terminal recombinogenicity, they generate clonal recombinant chromosomes with interstitial telomeric repeats. Losses of chromosomes 13, X, and 22, gains of 2, 3, 5, and 20, and translocation/deletion events involving several common chromosomal fragile sites (CFSs) were recurrent. Long-term reconstitution of telomerase activity in ALT cells reduced significantly the rates of random ongoing telomeric and pericentromeric CIN. However, the contribution of CFS in overall CIN remained unaffected, suggesting that in ALT cells whole-genome replication stress is not suppressed by telomerase activation. Our results provide novel insights into ALT-driven CIN, unveiling in parallel specific genomic sites that may harbor genes critical for ALT cancerous cell growth.

Entities:  

Mesh:

Year:  2013        PMID: 24339742      PMCID: PMC3858894          DOI: 10.1593/neo.131574

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  113 in total

Review 1.  Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint.

Authors:  P Silva; J Barbosa; A V Nascimento; J Faria; R Reis; H Bousbaa
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  Cytogenetic analysis and reporting.

Authors:  Lynda J Campbell
Journal:  Methods Mol Biol       Date:  2011

3.  Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines.

Authors:  Yi Zhang; Lin Cai; Ren-Xiong Wei; Hao Hu; Wei Jin; Xiao-Bin Zhu
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

Review 4.  Dicentric chromosomes: unique models to study centromere function and inactivation.

Authors:  Kaitlin M Stimpson; Justyne E Matheny; Beth A Sullivan
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

Review 5.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

6.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells.

Authors:  Susana Gonzalo; Isabel Jaco; Mario F Fraga; Taiping Chen; En Li; Manel Esteller; María A Blasco
Journal:  Nat Cell Biol       Date:  2006-03-26       Impact factor: 28.824

7.  Comprehensive karyotyping of the HT-29 colon adenocarcinoma cell line.

Authors:  Kanji Kawai; Carrie Viars; Karen Arden; David Tarin; Virginia Urquidi; Steve Goodison
Journal:  Genes Chromosomes Cancer       Date:  2002-05       Impact factor: 5.006

Review 8.  Alternative lengthening of telomeres in mammalian cells.

Authors:  Jeremy D Henson; Axel A Neumann; Thomas R Yeager; Roger R Reddel
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 9.  Chromosome fragile sites.

Authors:  Sandra G Durkin; Thomas W Glover
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

10.  Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.

Authors:  Kylie Bower; Christine E Napier; Sara L Cole; Rebecca A Dagg; Loretta M S Lau; Emma L Duncan; Elsa L Moy; Roger R Reddel
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more
  17 in total

Review 1.  Molecular mechanisms of activity and derepression of alternative lengthening of telomeres.

Authors:  Hilda A Pickett; Roger R Reddel
Journal:  Nat Struct Mol Biol       Date:  2015-11-04       Impact factor: 15.369

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Telomere length variation: A potential new telomere biomarker for lung cancer risk.

Authors:  Bing Sun; Ying Wang; Krishna Kota; Yaru Shi; Salaam Motlak; Kepher Makambi; Christopher A Loffredo; Peter G Shields; Qin Yang; Curtis C Harris; Yun-Ling Zheng
Journal:  Lung Cancer       Date:  2015-03-20       Impact factor: 5.705

4.  Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing.

Authors:  Panagiotis Galanos; Konstantinos Vougas; David Walter; Alexander Polyzos; Apolinar Maya-Mendoza; Emma J Haagensen; Antonis Kokkalis; Fani-Marlen Roumelioti; Sarantis Gagos; Maria Tzetis; Begoña Canovas; Ana Igea; Akshay K Ahuja; Ralph Zellweger; Sofia Havaki; Emanuel Kanavakis; Dimitris Kletsas; Igor B Roninson; Spiros D Garbis; Massimo Lopes; Angel Nebreda; Dimitris Thanos; J Julian Blow; Paul Townsend; Claus Storgaard Sørensen; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Nat Cell Biol       Date:  2016-06-20       Impact factor: 28.824

5.  Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian.

Authors:  Hongkun Wang; Ying Wang; Krishna K Kota; Bhaskar Kallakury; Nabiel N Mikhail; Douaa Sayed; Ahmed Mokhtar; Doaa Maximous; Etemad H Yassin; Iman Gouda; Adebiyi Sobitan; Bing Sun; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2015-09-05       Impact factor: 4.944

6.  Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication.

Authors:  Fani-Marlen Roumelioti; Sotirios K Sotiriou; Vasiliki Katsini; Maria Chiourea; Thanos D Halazonetis; Sarantis Gagos
Journal:  EMBO Rep       Date:  2016-10-19       Impact factor: 8.807

7.  A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Authors:  Eirini-Stavroula Komseli; Ioannis S Pateras; Thorbjørn Krejsgaard; Konrad Stawiski; Sophia V Rizou; Alexander Polyzos; Fani-Marlen Roumelioti; Maria Chiourea; Ioanna Mourkioti; Eleni Paparouna; Christos P Zampetidis; Sentiljana Gumeni; Ioannis P Trougakos; Dafni-Eleftheria Pefani; Eric O'Neill; Sarantis Gagos; Aristides G Eliopoulos; Wojciech Fendler; Dipanjan Chowdhury; Jiri Bartek; Vassilis G Gorgoulis
Journal:  BMC Genomics       Date:  2018-01-10       Impact factor: 3.969

8.  Telomere Length in Metaphase Chromosomes of Human Triploid Zygotes.

Authors:  Anna A Pendina; Mikhail I Krapivin; Olga A Efimova; Andrei V Tikhonov; Irina D Mekina; Evgeniia M Komarova; Alla S Koltsova; Alexander M Gzgzyan; Igor Yu Kogan; Olga G Chiryaeva; Vladislav S Baranov
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 9.  Telomere maintenance mechanisms in cancer: clinical implications.

Authors:  Roger R Reddel
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 10.  Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.

Authors:  Elisabeth Naderlinger; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2017-05-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.